XML 23 R12.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Segment Data | 9 Months Ended
--- | ---
Sep. 29, 2018
Segment Reporting [Abstract] |
Segment Data | Note 4 – Segment Data We conduct our business through two reportable segments: (i) health care distribution and (ii) technology and value-added services. These segments offer different products and services to the same customer base. The health care distribution reportable segment aggregates our global dental, animal health and medical operating segments. This segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and ge neric pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. Our global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions. Our global animal health group serves animal health practices and clinics. Our global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. Our global dental, animal health and medical groups s erve practitioners in 34 countries worldwide. Our global technology and value-added services group provides software, technology and other value-added services to health care practitioners. Our technology group offerings include practic e management software systems for dental and medical practitioners and animal health clinics. Our value-added practice solutions include financial services on a non-recourse basis, e-services, continuing education services for practitioners, consulting an d other services. The following tables present information about our reportable and operating segments:
|  |  |  |  | Three Months Ended |  | Nine Months Ended
|  |  |  |  | September 29, |  | September 30, |  | September 29, |  | September 30,
|  |  |  |  | 2018 |  | 2017 |  | 2018 |  | 2017
Net Sales: |  |  |  |  |  |  |  |  |  |  |  |
| Health care distribution (1): |  |  |  |  |  |  |  |  |  |  |  |
|  | Dental |  | $ | 1,514,538 |  | $ | 1,478,730 |  | $ | 4,675,212 |  | $ | 4,372,055
|  | Animal health |  |  | 899,295 |  |  | 882,580 |  |  | 2,805,031 |  |  | 2,586,850
|  | Medical |  |  | 721,942 |  |  | 690,761 |  |  | 1,976,367 |  |  | 1,861,074
|  |  | Total health care distribution |  |  | 3,135,775 |  |  | 3,052,071 |  |  | 9,456,610 |  |  | 8,819,979
| Technology and value-added services (2) |  |  | 143,903 |  |  | 109,012 |  |  | 370,183 |  |  | 323,510
|  | Total |  | $ | 3,279,678 |  | $ | 3,161,083 |  | $ | 9,826,793 |  | $ | 9,143,489
(1) | Consists of consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and
| generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
(2) | Consists of practice management software and other value-added products, which are distributed primarily to health care providers,
| and financial services on a non-recourse basis, e-services, continuing education services for practitioners, consulting and other
| services.
|  |  |  |  | Three Months Ended |  | Nine Months Ended
|  |  |  |  | September 29, |  | September 30, |  | September 29, |  | September 30,
|  |  |  |  | 2018 |  | 2017 |  | 2018 |  | 2017
Operating Income: |  |  |  |  |  |  |  |  |  |  |  |
| Health care distribution |  | $ | 127,990 |  | $ | 181,612 |  | $ | 471,543 |  | $ | 521,278
| Technology and value-added services |  |  | 37,936 |  |  | 31,936 |  |  | 101,874 |  |  | 96,900
|  | Total |  | $ | 165,926 |  | $ | 213,548 |  | $ | 573,417 |  | $ | 618,178

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -URI http://asc.fasb.org/topic&trid=2134510 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration